CMLAX
Price
$57.78
Change
-$0.05 (-0.09%)
Updated
Jun 5 closing price
Net Assets
105.22B
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

CMLAX vs RMEBX

Header iconCMLAX vs RMEBX Comparison
Open Charts CMLAX vs RMEBXBanner chart's image
American Funds American Mutual 529A
Price$57.78
Change-$0.05 (-0.09%)
VolumeN/A
Net Assets105.22B
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
CMLAX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CMLAX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMLAX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CMLAX (105B) and RMEBX (105B) have equal amount of cash in the bank . CMLAX pays higher dividends than RMEBX: CMLAX (1.58) vs RMEBX (1.16). CMLAX was incepted earlier than RMEBX: CMLAX (23 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than CMLAX (0.61). CMLAX (31.00) and RMEBX (31.00) have comparable annual turnover. CMLAX (250) and RMEBX (250) have matching initial minimum investment requirements. CMLAX annual gain was more profitable for investors over the last year : 8.81 vs. RMEBX (8.30). CMLAX return over 5 years is better than : 53.33 vs. RMEBX (49.85).
CMLAXRMEBXCMLAX / RMEBX
Total Expense Ratio0.611.0757%
Annual Report Gross Expense Ratio0.611.0757%
Fund Existence23 years11 years-
Gain YTD5.5565.349104%
Front Load4%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets105B105B100%
Annual Yield % from dividends1.581.16137%
Returns for 1 year8.818.30106%
Returns for 3 years19.6017.96109%
Returns for 5 years53.3349.85107%
Returns for 10 years90.0268.21132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA